Onc dx rectal t1-3,n1-2noprg
Full descriptor
Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n1-2, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence or metastases (for use in a medicare-approved demonstration project)
Details
- Code
- G9092
- Short descriptor
- Onc dx rectal t1-3,n1-2noprg
- Code set
- HCPCS Level II
- Release
- July 2026
- Status
- Active
- Added
- Jan 1 2006
Nearby codes
Code sets are published in blocks, so neighbours are usually related.
Onc dx rectal t3 n0 no prog
Onc dx rectal t4,n,m0 no prg
Onc dx rectal t1-2 no progr
Onc dx rectal m1 w/mets prog
Onc dx rectal extent unknwn
Onc dx colon extent unknown
Onc dx esophag t1-t3 noprog
Onc dx colon metas noevid dx
Sources
- CMS HCPCS Level II — July 2026, public domain
Reference information only. Not billing advice. Verify against the payer before you file.